Alcami Adds to Analytical Capabilities
Part of the special news roundup of DCAT member companies for the DCAT Week ’17 Special Edition of DCAT Value Chain Insights (April 5, 2017)
Alcami, a provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, added to its analytical capabilities in pharmaceutical formulation development with the addition of a new high-throughput X-ray diffraction (XRD) analysis system from Bruker AXS, a Karlsruhe, Germany-based supplier of analytical X-ray solutions.
The new XRD analysis system, Bruker’s D8 Discover HTS, was added to Alcami’s site in Weert, The Netherlands. As part of a collaboration agreement, Alcami will use the D8 Dicover HTS to add XRD capabilities to their laboratory service portfolio and make it available as part of their workflow-integrated solution as of the third quarter of 2017.
The D8 Discover HTS combines advanced sample analysis throughput capabilities with flexibility and matches application requirements in the pharmaceutical industry for crystallization studies, polymorph screening, structure solution, phase identification, and crystallite size determination under ambient and non-ambient conditions. The system is a multi-purpose X-ray diffractometer platform that can be reconfigured without time-consuming alignment, which can increase time for data collection, according to Alcami.